UVV
Universal Corporation
NYSE · Consumer Defensive · Tobacco · US
$45.54
−0.98%Year over year
Reported trailing growth
- Revenue
- -3.0%
- EBITDA
- -36.7%
- EBIT
- -29.5%
- EPS
- -81.6%
- Free cash flow
- +24.1%
- Operating cash flow
- +17.8%
Forward estimates
Based on analyst estimates
- Revenue
- -4.6%
- EBITDA
- +31.5%
- EPS
- +342.1%
Three-year CAGR
- Revenue
- +4.4%
- EBITDA
- -2.5%
- EBIT
- +5.3%
- Net income
- -35.9%
- EPS
- -36.2%
- Free cash flow
- -69.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026